Mitochondrial Pyruvate Carrier Abundance Mediates Pathological Cardiac Hypertrophy

Researchers showed that mitochondrial pyruvate carrier (MPC) abundance mediates pathological cardiac hypertrophy. MPC abundance was reduced in failing hypertrophic human hearts, as well as in the myocardium of mice induced to fail by angiotensin II or through transverse aortic constriction.
[Nature Metabolism]
Fernandez-Caggiano, M., Kamynina, A., Francois, A. A., Prysyazhna, O., Eykyn, T. R., Krasemann, S., Crespo-Leiro, M. G., Vieites, M. G., Bianchi, K., Morales, V., Domenech, N., & Eaton, P. (2020). Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. Nature Metabolism, 1–9. https://doi.org/10.1038/s42255-020-00276-5 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Inhibition of Aquaporin-1 Prevents Myocardial Remodeling by Blocking the Transmembrane Transport of Hydrogen Peroxide

Researchers showed that hydrogen peroxide (H2O2), produced extracellularly, was necessary for the hypertrophic response of isolated cardiac myocytes and that aquaporin-1 facilitated the transmembrane transport of H2O2 through its water pore, resulting in activation of oxidant-sensitive kinases in cardiac myocytes.
[Science Translational Medicine]
Montiel, V., Bella, R., Michel, L. Y. M., Esfahani, H., Mulder, D. D., Robinson, E. L., Deglasse, J.-P., Tiburcy, M., Chow, P. H., Jonas, J.-C., Gilon, P., Steinhorn, B., Michel, T., Beauloye, C., Bertrand, L., Farah, C., Zotti, F. D., Debaix, H., Bouzin, C., … Balligand, J.-L. (2020). Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide. Science Translational Medicine, 12(564). https://doi.org/10.1126/scitranslmed.aay2176 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Hydrojet-Based Delivery of Footprint-Free iPSC-Derived Cardiomyocytes Into Porcine Myocardium

Scientists analyzed the applicability of a hydrojet-based method to deliver footprint-free iPSC-derived cardiomyocytes into the myocardium.
[Scientific Reports]
Weber, M., Fech, A., Jäger, L., Steinle, H., Bühler, L., Perl, R. M., Martirosian, P., Mehling, R., Sonanini, D., Aicher, W. K., Nikolaou, K., Schlensak, C., Enderle, M. D., Wendel, H. P., Linzenbold, W., & Avci-Adali, M. (2020). Hydrojet-based delivery of footprint-free iPSC-derived cardiomyocytes into porcine myocardium. Scientific Reports, 10(1), 16787. https://doi.org/10.1038/s41598-020-73693-x Cite
Full Article
Bookmark

No account yet? Register

0
Share

Liposomal Delivery of Azithromycin Enhances Its Immunotherapeutic Efficacy and Reduces Toxicity in Myocardial Infarction

Scientists investigated the immunomodulatory role of a liposomal azithromycin formulation in a clinically relevant model to enhance its therapeutic potency and avoid off-target effects.
[Scientific Reports]
Al-Darraji, A., Donahue, R. R., Tripathi, H., Peng, H., Levitan, B. M., Chelvarajan, L., Haydar, D., Gao, E., Henson, D., Gensel, J. C., Feola, D. J., Venditto, V. J., & Abdel-Latif, A. (2020). Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction. Scientific Reports, 10(1), 16596. https://doi.org/10.1038/s41598-020-73593-0 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Cardiomyocyte Induction and Regeneration for Myocardial Infarction Treatment: Cell Sources and Administration Strategies

The authors briefly survey cell sources and delivery strategies, along with biomaterials and their processing techniques, developed for myocardial infarction treatment. Key issues and challenges, as well as recommendations for future research, are also discussed.
[Advanced Healthcare Materials]
Abstract
Bookmark

No account yet? Register

0
Share

NOTCH1 Is Critical for Fibroblast-Mediated Induction of Cardiomyocyte Specialization Into Ventricular Conduction System-Like Cells In Vitro

Fibroblast-conditioned media (fCM)-mediated response seemed to be spatially-dependent as cardiomyocyte organoids treated with fCM had increased expression of connexin 40 and NAV1.5 primarily on its outer surface.
[Scientific Reports]
Ribeiro da Silva, A., Neri, E. A., Turaça, L. T., Dariolli, R., Fonseca-Alaniz, M. H., Santos-Miranda, A., Roman-Campos, D., Venturini, G., & Krieger, J. E. (2020). NOTCH1 is critical for fibroblast-mediated induction of cardiomyocyte specialization into ventricular conduction system-like cells in vitro. Scientific Reports, 10(1), 16163. https://doi.org/10.1038/s41598-020-73159-0 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Infarct Collagen Topography Regulates Fibroblast Fate via p38-Yap-TEAD Signals

Adult cardiac fibroblasts were freshly isolated and cultured on ECM topographical mimetics for 72 hours. Aligned mimetics caused cardiac fibroblasts to elongate while randomly organized topographies induced circular morphology similar to the disparate myofibroblast morphologies measured in vivo.
[Circulation Research]
Bugg Darrian, Bretherton Ross C, Kim Peter, Olszewski Emily, Nagle Abigail, Schumacher Austin E, Chu Nickolas, Gunaje Jagadambika, DeForest Cole A, Stevens Kelly, Kim Deok-Ho, & Davis Jennifer M. (n.d.). Infarct Collagen Topography Regulates Fibroblast Fate Via p38-Yap-TEAD Signals. Circulation Research, 0(0). https://doi.org/10.1161/CIRCRESAHA.119.316162 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Soft Matrix Promotes Cardiac Reprogramming via Inhibition of YAP/TAZ and Suppression of Fibroblast Signatures

Researchers developed a matrigel-based hydrogel culture system to determine the roles of matrix stiffness and mechanotransduction in cardiac reprogramming. They found that soft matrix comparable with native myocardium promoted the efficiency and quality of cardiac reprogramming.
[Stem Cell Reports]
Kurotsu, S., Sadahiro, T., Fujita, R., Tani, H., Yamakawa, H., Tamura, F., Isomi, M., Kojima, H., Yamada, Y., Abe, Y., Murakata, Y., Akiyama, T., Muraoka, N., Harada, I., Suzuki, T., Fukuda, K., & Ieda, M. (2020). Soft Matrix Promotes Cardiac Reprogramming via Inhibition of YAP/TAZ and Suppression of Fibroblast Signatures. Stem Cell Reports, 0(0). https://doi.org/10.1016/j.stemcr.2020.07.022 Cite
Full ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

Intramyocardial Transplantation of Umbilical Cord Mesenchymal Stromal Cells in Chronic Ischemic Cardiomyopathy: A Controlled, Randomized Clinical Trial (HUC-HEART Trial)

54 patients were randomized to receive human umbilical cord-MSCs or bone-marrow-derived mononuclear cells in combination with coronary artery bypass-grafting (CABG) surgery. The control patients received no cells/vehicles but CABG intervention.
[International Journal of Stem Cells]
Ulus, A. T., Mungan, C., Kurtoglu, M., Celikkan, F. T., Akyol, M., Sucu, M., Toru, M., Gul, S. S., Cinar, O., & Can, A. (n.d.). Intramyocardial Transplantation of Umbilical Cord Mesenchymal Stromal Cells in Chronic Ischemic Cardiomyopathy: A Controlled, Randomized Clinical Trial (HUC-HEART Trial). International Journal of Stem Cells. https://doi.org/10.15283/ijsc20075 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Modified mRNA as a Therapeutic Tool for the Heart

The authors present a comprehensive overview of modified mRNA’s role in cardiomyocyte proliferation, cardiac vascularization, and prevention of cardiac apoptosis.
[Cardiovascular Drugs and Therapy]
Kaur, K., & Zangi, L. (2020). Modified mRNA as a Therapeutic Tool for the Heart. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-020-07051-4 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Dynamics of Cardiac Neutrophil Diversity in Murine Myocardial Infarction

Investigators employed single-cell transcriptomics combined with cell surface epitope detection by sequencing to investigate temporal neutrophil diversity in the blood and heart after murine myocardial infarction.
[Circulation Research]
Abstract
Bookmark

No account yet? Register

0
Share
Share